Ambulatory blood pressure monitoring profiles in Asia

Author:

Widyantoro Bambang1ORCID,Nailes Jennifer M.2ORCID,Sukonthasarn Apichard3,Soenarta Arieska Ann1,

Affiliation:

1. Department of Cardiology and Vascular Medicine Faculty of Medicine Universitas Indonesia – National Cardiovascular Center Harapan Kita Jakarta Indonesia

2. Department of Preventive and Community Medicine University of the East Ramon Magsaysay Memorial Medical Center Research Institute for Health Sciences Manila Philippines

3. Cardiovascular Division Department of Medicine Faculty of Medicine Chiang Mai University Chiang Mai Thailand

Abstract

AbstractHigh blood pressure (BP) remains a major health problem globally, with a proportion of hypertension‐mediated organ damage (HMOD) increasing worldwide including in Asia region. Cardiovascular (CV), cerebral and kidney diseases related to hypertension were reported to be closely associated with morning surge and nocturnal hypertension—a subset of BP variability—which can be detected by out‐of‐office BP measurement. Ambulatory BP monitoring (ABPM) and Home BP monitoring (HBPM) have been recommended by major guidelines to be used in the evaluation of BP variability and outcomes’ prediction of hypertension patients. However, an interesting profile of ABPM in Asia has been reported and hypothesized to correlate with different outcomes. This review will focus on the current recommendation of ABPM use by the guidelines, the major different profiles of ABPM in Asia as compared to Western countries according to clinical indications, and the challenges in implementing optimal use of ABPM in Asian countries based on available evidence.

Publisher

Wiley

Reference50 articles.

1. Global disparities of hypertension prevalence and control: a systematic analysis of population‐based studies from 90 countries;Mills KT;Circulation,2016

2. OstchegaY FryarCD NwankwoT NguyenDT Hypertension prevalence among adults aged 18 and over: United States 2017–2018. 2020.

3. Potential US Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline

4. World Health O.Noncommunicable diseases progress monitor 2022. 2022.

5. Advancing hypertension management in Asia 2021, beyond COVID‐19;Schutte AE;J Clin Hypertens,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3